Lewis C. Cantley | |
|---|---|
| Born | February 20, 1949 West Virginia, U.S. |
| Alma mater | West Virginia Wesleyan College Cornell University |
| Known for | PI-3-kinase Phosphatidylinositol (3,4,5)-trisphosphate Oriented Peptide Libraries/Scansite Phosphatidylinositol 5-phosphate |
| Scientific career | |
| Fields | Biochemistry Cell Biology Systems Biology |
| Institutions | Weill Cornell Medical College Harvard Medical School Beth Israel Deaconess Medical Center Tufts University Harvard University |
| Doctoral advisor | Gordon Hammes |
| Other academic advisors | Guido Guidotti |
Lewis C. Cantley (born February 20, 1949) is an American cell biologist and biochemist who has made significant advances to the understanding of cancer metabolism. Among his most notable contributions are the discovery and study of the enzyme PI-3-kinase, now known to be important to understanding cancer and diabetes mellitus.[1][2] He is currently Meyer Director and Professor of Cancer Biology at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine in New York City. He was formerly a professor in the Departments of Systems Biology and Medicine at Harvard Medical School, and the Director of Cancer Research at the Beth Israel Deaconess Medical Center, in Boston, Massachusetts. In 2016, he was elected Chairman of the Board for the Hope Funds for Cancer Research.